Lynn Sosa, MD
Assistant Professor Adjunct; Principal Investigator, Connecticut Emerging Infections Program; Assistant Clinical Professor of Epidemiology (Microbial Diseases)
Research & Publications
Biography
Selected Publications
- Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial TearsGrossman M, Rankin D, Maloney M, Stanton R, Gable P, Stevens V, Ewing T, Saunders K, Kogut S, Nazarian E, Bhaurla S, Mephors J, Mongillo J, Stonehocker S, Prignano J, Valencia N, Charles A, McNamara K, Fritsch W, Ruelle S, Plucinski C, Sosa L, Ostrowsky B, Ham D, Walters M, Aguilar H, Alavi A, Balbuena R, Braut-Taormina J, Bruce H, Chambers W, Chen K, Clancy K, Cockrell M, Crayton K, Cyrus M, D'Angeli M, Diaz M, Dollete J, Eskenazi S, Fong L, Giardina R, Gogley J, Greendyke W, Hadman S, Houston H, Huck C, Istafanos P, Jean-Louis A, Jones D, Kratz M, Kwan T, La S, Lance S, Lasure M, Longo C, Machado M, McAllister G, McGarry S, McKay S, Miller D, Musk M, O'Yong K, Patel E, Pightling A, Rodriguez A, Rogers J, Romero H, Satyam M, Silverman M, Skolek G, Smith A, Stahl A, Torres L, Trivedi K, Wilmott N. Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears. Clinical Infectious Diseases 2024, ciae052. PMID: 38315890, DOI: 10.1093/cid/ciae052.
- Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023Dalton A, Diallo A, Chard A, Moulia D, Deputy N, Fothergill A, Kracalik I, Wegner C, Markus T, Pathela P, Still W, Hawkins S, Mangla A, Ravi N, Licherdell E, Britton A, Lynfield R, Sutton M, Hansen A, Betancourt G, Rowlands J, Chai S, Fisher R, Danza P, Farley M, Zipprich J, Prahl G, Wendel K, Niccolai L, Castilho J, Payne D, Cohn A, Feldstein L, Group C, Group C, Saadeh K, Snyder R, Anderson M, Anguiano V, Nadle J, Rothrock G, Jones S, Duval L, Herlihy R, Stringer G, Weber R, Phan Q, Sosa L, Meek J, Lee M, Morrow A, Willut C, Carlson J, Kamis K, Nishiyama M, Simien G, Colasanti J, van der Woude T, Archer R, Finn L, Lam J, Moulton B, Peterson E, Bolan R, Garcia-Lopez G, Como-Sabetti K, Ruff A, Schneider D, Robinson T, Anderson B, Engesser K, McGuire S, Rowe A, Pride C, Mitchell J, Tourkina Y, Cieslak P, Fill M, Wiedeman C, Dumyati G, Felsen C, Lewnard J, Akoko B, Mansilla-Dubon K, Ndi D, Talbot H, Tiwari S, Wyatt D. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023. MMWR Morbidity And Mortality Weekly Report 2023, 72: 553-558. PMID: 37200229, PMCID: PMC10205167, DOI: 10.15585/mmwr.mm7220a3.
- Epidemiologic and Clinical Features of Children and Adolescents Aged <18 Years with Monkeypox — United States, May 17–September 24, 2022Hennessee I, Shelus V, McArdle C, Wolf M, Schatzman S, Carpenter A, Minhaj F, Petras J, Cash-Goldwasser S, Maloney M, Sosa L, Jones S, Mangla A, Harold R, Beverley J, Saunders K, Adams J, Stanek D, Feldpausch A, Pavlick J, Cahill M, O’Dell V, Kim M, Alarcón J, Finn L, Goss M, Duwell M, Crum D, Williams T, Hansen K, Heddy M, Mallory K, McDermott D, Cuadera M, Adler E, Lee E, Shinall A, Thomas C, Ricketts E, Koonce T, Rynk D, Cogswell K, McLafferty M, Perella D, Stockdale C, Dell B, Roskosky M, White S, Davis K, Milleron R, Mackey S, Barringer L, Bruce H, Barrett D, D’Angeli M, Kocharian A, Klos R, Dawson P, Ellington S, Mayer O, Godfred-Cato S, Labuda S, McCormick D, McCollum A, Rao A, Salzer J, Kimball A, Gold J, Group C, Group C, Group C, Berumen R, Cosentino G, Getabecha S, Glaser C, Grosgebauer K, Harriman K, Haw M, Kamali A, Kath C, Kim E, Lewis L, Sachdev D, Salas M, Stainken C, Wadford D, Peters P, Vaidya A, Group C, Adkins S, Baird ;, Barrios L, Beeson A, Blackburn D, Borah B, Click E, Davidson W, Galang R, Hufstetler K, Hutchins H, Kourtis A, Miller M, Morris S, Olsen E, Roth N, Sims E, Chatham-Stephens K. Epidemiologic and Clinical Features of Children and Adolescents Aged <18 Years with Monkeypox — United States, May 17–September 24, 2022. MMWR Morbidity And Mortality Weekly Report 2022, 71: 1407-1411. PMID: 36331124, PMCID: PMC9639439, DOI: 10.15585/mmwr.mm7144a4.
- SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022Baker J, Nakayama J, O’Hegarty M, McGowan A, Teran R, M. S, Mosack K, Roberts N, Campos B, Paegle A, McGee J, Herrera R, English K, Barrios C, Davis A, Roloff C, Sosa L, Brockmeyer J, Page L, Bauer A, Weiner J, Khubbar M, Bhattacharyya S, Kirking H, Tate J. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022. MMWR Morbidity And Mortality Weekly Report 2022, 71: 341-346. PMID: 35238860, PMCID: PMC8893332, DOI: 10.15585/mmwr.mm7109e1.
- Treatment Guidelines for Active Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis, and Latent Tuberculosis InfectionSosa L, Friedman L. Treatment Guidelines for Active Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis, and Latent Tuberculosis Infection. 2020, 393-398. DOI: 10.1201/9781351249980-20.
- Notes from the Field: Powassan Virus Disease in an Infant — Connecticut, 2016Tutolo J, Staples J, Sosa L, Bennett N. Notes from the Field: Powassan Virus Disease in an Infant — Connecticut, 2016. MMWR Morbidity And Mortality Weekly Report 2017, 66: 408-409. PMID: 28426641, PMCID: PMC5687186, DOI: 10.15585/mmwr.mm6615a3.